This inventor holds 2 USPTO granted patents and 6 published patent applications. Top assignee: Certego Therapeutics Inc.. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Pavel Osten: Innovator in Psychiatric Treatment
Introduction
Pavel Osten is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of psychiatric treatment through his innovative patents. With a total of 2 patents, Osten's work focuses on improving therapeutic options for patients suffering from psychiatric disorders.
Latest Patents
Osten's latest patents include "Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders" and "Gaboxadol for reducing risk of suicide and rapid relief of depression." The first patent describes ring deuterated gaboxadol, which is shown to be more effective than its non-deuterated counterpart in treating psychiatric disorders. This compound can be used in combination with other medications to enhance therapeutic effects. The second patent outlines methods for rapidly reducing the risk of suicide in patients experiencing acute suicidality and providing quick relief from mood symptoms in major depression and treatment-resistant depression through a novel therapeutic regimen involving gaboxadol.
Career Highlights
Osten is currently associated with Certego Therapeutics Inc., where he continues to develop innovative solutions for mental health challenges. His work is characterized by a commitment to advancing psychiatric treatment options and improving patient outcomes.
Collaborations
Some of his notable coworkers include Kristin K Baldwin and Robert J DeVita, who contribute to the collaborative efforts at Certego Therapeutics Inc.
Conclusion
Pavel Osten's contributions to psychiatric treatment through his patents highlight his dedication to innovation in mental health care. His work not only advances scientific understanding but also offers hope for improved therapies for patients in need.